However, AMPKα2 deletion caused malignant activation of the mTORC1 signaling pathway, resulting in exacerbated cardiac hypertrophy and dysfunction (Zhang et al., 2008). The gene discussed is PRKAA2; the disease is cardiac hypertrophy.